{"id":69360,"date":"2023-08-08T09:57:03","date_gmt":"2023-08-08T04:27:03","guid":{"rendered":"http:\/\/finservwealth.com\/torrent-pharma-hits-52-week-high-as-brokerages-chart-positive-growth-trajectory\/"},"modified":"2023-08-08T09:57:03","modified_gmt":"2023-08-08T04:27:03","slug":"torrent-pharma-hits-52-week-high-as-brokerages-chart-positive-growth-trajectory","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/torrent-pharma-hits-52-week-high-as-brokerages-chart-positive-growth-trajectory\/","title":{"rendered":"Torrent Pharma hits 52-week high as brokerages chart positive growth trajectory"},"content":{"rendered":"<p> Industry-beating growth of 14.5 percent in the domestic formulations market coupled with an increase in sales in Brazil and Germany helped Torrent Pharma offset weak revenues from its US business.<\/p><div id=\"finse-1360618581\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/torrent-pharma-hits-52-week-high-as-brokerages-chart-positive-growth-trajectory_17162651.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Industry-beating growth of 14.5 percent in the domestic formulations market coupled with an increase in sales in Brazil and Germany helped Torrent Pharma offset weak revenues from its US business. Industry-beating growth of 14.5 percent in the domestic formulations market coupled with an increase in sales in Brazil and Germany helped Torrent Pharma offset weak revenues from its US business.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/torrent-pharma-hits-52-week-high-as-brokerages-chart-positive-growth-trajectory_17162651.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Industry-beating growth of 14.5 percent in the domestic formulations market coupled with an increase in sales in Brazil and Germany helped Torrent Pharma offset weak revenues from its US business.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/torrent-pharma-hits-52-week-high-as-brokerages-chart-positive-growth-trajectory_17162651.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Industry-beating growth of 14.5 percent in the domestic formulations market coupled with an increase in sales in Brazil and Germany helped Torrent Pharma offset weak revenues from its US business. Industry-beating growth of 14.5 percent in the domestic formulations market coupled with an increase in sales in Brazil and Germany helped Torrent Pharma offset weak revenues from its US business.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/torrent-pharma-hits-52-week-high-as-brokerages-chart-positive-growth-trajectory_17162651.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Industry-beating growth of 14.5 percent in the domestic formulations market coupled with an increase in sales in Brazil and Germany helped Torrent Pharma offset weak revenues from its US business.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-69360","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2020\/200x200\/T\/TORRENT-PHARMA_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/69360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=69360"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/69360\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=69360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=69360"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=69360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}